Neo Ivy Capital Management’s Acadia Healthcare ACHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-11,968
Closed -$758K 259
2024
Q3
$758K Buy
+11,968
New +$864K 0.25% 152
2023
Q4
$1K Buy
+13
New +$962 ﹤0.01% 265
2022
Q4
$109K Buy
1,326
+1,257
+1,822% +$104K 0.07% 258
2022
Q3
$5K Buy
+69
New +$5.51K 0.01% 343
2021
Q4
Sell
-1,412
Closed -$35K 419
2021
Q3
$35K Buy
+1,412
New +$89.1K 0.04% 358
2021
Q2
Sell
-6,514
Closed -$372K 426
2021
Q1
$372K Buy
+6,514
New +$352K 0.41% 78
2020
Q3
Sell
-1,412
Closed -$35K 449
2020
Q2
$35K Buy
+1,412
New +$35.2K 0.04% 358
2020
Q1
Sell
-131
Closed -$4K 448
2019
Q4
$4K Buy
+131
New +$4.11K ﹤0.01% 240

Other funds holding ACHC

Neo Ivy Capital Management's ACHC Position: Q4 2024 in Review

Neo Ivy Capital Management sold out of Acadia Healthcare (ACHC) in Q4 2024, closing a stake of 11,968 shares — an estimated $758K sold.

Neo Ivy Capital Management first reported a position in ACHC in Q4 2019 and held it in 8 quarters. The position peaked at $758K in Q3 2024. 306 funds tracked by Wall St. Rank hold ACHC as of Q4 2024.

  • Neo Ivy Capital Management reported no remaining Acadia Healthcare position as of Q4 2024 after selling out during the quarter.
  • Neo Ivy Capital Management sold 11,968 Acadia Healthcare shares in Q4 2024, an estimated $758K.
  • Neo Ivy Capital Management first reported a position in Acadia Healthcare in Q4 2019 and held it in 8 quarters.
  • Neo Ivy Capital Management's Acadia Healthcare position peaked at $758K in Q3 2024.
  • 306 funds tracked by Wall St. Rank held Acadia Healthcare as of Q4 2024.

Based on Neo Ivy Capital Management's 13F filing for Q4 2024, filed 18 Feb 2025.